US Stock MarketDetailed Quotes

CNBX CNBX Pharmaceuticals

Watchlist

0.007500
-0.001200-13.79%

15min DelayClose Nov 29 13:00 ET

233.34KMarket Cap-375P/E (TTM)

CNBX Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Aug 31, 2024

(Q4)Aug 31, 2024

(Q3)May 31, 2024

(Q2)Feb 29, 2024

(Q1)Nov 30, 2023

(FY)Aug 31, 2023

(Q4)Aug 31, 2023

(Q3)May 31, 2023

(Q2)Feb 28, 2023

(Q1)Nov 30, 2022

Assets

Current assets

Cash, cash equivalents and short term investments

-79.63%26.42K

66.26%73.41K

-22.21%37.14K

278.00%81.65K

10.37%129.7K

-54.14%44.15K

-79.39%47.75K

-97.25%21.6K

-Cash and cash equivalents

-79.63%26.42K

66.26%73.41K

-22.21%37.14K

278.00%81.65K

10.37%129.7K

-54.14%44.15K

-79.39%47.75K

-97.25%21.6K

Receivables

-94.75%4.97K

-97.83%6.62K

107.53%126.78K

-11.26%69.29K

17.13%94.61K

121.05%304.65K

-63.63%61.09K

-56.17%78.09K

-Other receivables

-94.75%4.97K

-97.83%6.62K

107.53%126.78K

-11.26%69.29K

17.13%94.61K

121.05%304.65K

-63.63%61.09K

-56.17%78.09K

Total current assets

-86.01%31.38K

-77.06%80.03K

50.61%163.92K

51.41%150.94K

13.12%224.31K

49.00%348.8K

-72.76%108.84K

-89.67%99.69K

Non current assets

Net PPE

--0

-39.92%236.47K

-37.10%274.73K

-36.36%313.22K

-34.71%353.22K

-33.47%393.61K

Investments and advances

--0

----

--0

-79.39%116.22K

Total non current assets

--0

-53.62%236.47K

-55.17%274.73K

-57.19%313.22K

-52.15%353.22K

-55.88%509.82K

Total assets

-93.71%31.38K

-87.91%80.03K

-64.52%163.92K

-36.44%387.4K

-38.48%499.04K

-31.45%662.02K

-59.39%462.05K

-71.25%609.51K

Liabilities

Current liabilities

Payables

3.71%1.22M

0.13%1.24M

31.65%1.23M

42.37%1.17M

71.26%1.17M

128.06%1.24M

102.72%934.19K

93.48%820.56K

-accounts payable

-87.84%40.84K

-81.30%189.82K

-67.44%231.38K

-58.84%245.71K

-27.15%335.92K

217.67%1.02M

199.57%710.55K

197.79%596.91K

-Due to related parties current

40.46%1.18M

369.82%1.05M

346.46%998.48K

312.48%922.5K

274.18%836.83K

0.00%223.65K

Current debt and capital lease obligation

-3.61%1.3M

-2.91%1.29M

-16.03%1.29M

-25.47%1.31M

-23.60%1.34M

-16.97%1.33M

16.18%1.54M

65.00%1.76M

-Current debt

-3.61%1.3M

-2.91%1.29M

-16.03%1.29M

-25.47%1.31M

-23.60%1.34M

-16.97%1.33M

16.18%1.54M

65.00%1.76M

Current liabilities

-0.20%2.51M

-1.44%2.53M

1.98%2.52M

-3.93%2.48M

2.98%2.52M

19.70%2.57M

38.51%2.47M

73.09%2.58M

Non current liabilities

Total non current liabilities

--0

---1

--0

Total liabilities

-0.20%2.51M

-1.44%2.53M

1.98%2.52M

-3.93%2.48M

2.98%2.52M

19.70%2.57M

38.51%2.47M

73.09%2.58M

Shareholders'equity

Share capital

37.59%3.11K

94.07%3.11K

1,301.35%3.11K

2,183.06%2.83K

1,723.39%2.26K

1,192.74%1.6K

-98.49%222

-99.14%124

-common stock

37.59%3.11K

94.07%3.11K

1,301.35%3.11K

2,183.06%2.83K

1,723.39%2.26K

1,192.74%1.6K

-98.49%222

-99.14%124

-Preferred stock

----

--0

----

--0

Retained earnings

-2.87%-24.95M

-5.10%-24.89M

-5.24%-24.76M

-16.89%-24.44M

-18.06%-24.26M

-18.02%-23.69M

-21.37%-23.53M

-15.20%-20.91M

Paid-in capital

1.04%22.47M

20.33%22.44M

21.81%22.4M

23.37%22.34M

23.34%22.24M

3.94%18.65M

3.21%18.39M

3.54%18.11M

Gains losses not affecting retained earnings

--0

----

--0

86.82%-330.93K

87.04%-330.93K

-20.48%-2.63M

Other equity interest

----

0.00%3.46M

Total stockholders'equity

-22.94%-2.48M

-28.54%-2.45M

-17.25%-2.36M

-6.11%-2.09M

-23.58%-2.02M

-61.48%-1.91M

-210.41%-2.01M

-414.67%-1.97M

Total equity

-22.94%-2.48M

-28.54%-2.45M

-17.25%-2.36M

-6.11%-2.09M

-23.58%-2.02M

-61.48%-1.91M

-210.41%-2.01M

-414.67%-1.97M

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(FY)Aug 31, 2024	(Q4)Aug 31, 2024	(Q3)May 31, 2024	(Q2)Feb 29, 2024	(Q1)Nov 30, 2023	(FY)Aug 31, 2023	(Q4)Aug 31, 2023	(Q3)May 31, 2023	(Q2)Feb 28, 2023	(Q1)Nov 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments	-79.63%26.42K	-79.63%26.42K	66.26%73.41K	-22.21%37.14K	278.00%81.65K	10.37%129.7K	10.37%129.7K	-54.14%44.15K	-79.39%47.75K	-97.25%21.6K
-Cash and cash equivalents	-79.63%26.42K	-79.63%26.42K	66.26%73.41K	-22.21%37.14K	278.00%81.65K	10.37%129.7K	10.37%129.7K	-54.14%44.15K	-79.39%47.75K	-97.25%21.6K
Receivables	-94.75%4.97K	-94.75%4.97K	-97.83%6.62K	107.53%126.78K	-11.26%69.29K	17.13%94.61K	17.13%94.61K	121.05%304.65K	-63.63%61.09K	-56.17%78.09K
-Other receivables	-94.75%4.97K	-94.75%4.97K	-97.83%6.62K	107.53%126.78K	-11.26%69.29K	17.13%94.61K	17.13%94.61K	121.05%304.65K	-63.63%61.09K	-56.17%78.09K
Total current assets	-86.01%31.38K	-86.01%31.38K	-77.06%80.03K	50.61%163.92K	51.41%150.94K	13.12%224.31K	13.12%224.31K	49.00%348.8K	-72.76%108.84K	-89.67%99.69K
Non current assets
Net PPE	--0	--0	--0	--0	-39.92%236.47K	-37.10%274.73K	-37.10%274.73K	-36.36%313.22K	-34.71%353.22K	-33.47%393.61K
Investments and advances	--0	--0	----	----	----	--0	--0	--0	--0	-79.39%116.22K
Total non current assets	--0	--0	--0	--0	-53.62%236.47K	-55.17%274.73K	-55.17%274.73K	-57.19%313.22K	-52.15%353.22K	-55.88%509.82K
Total assets	-93.71%31.38K	-93.71%31.38K	-87.91%80.03K	-64.52%163.92K	-36.44%387.4K	-38.48%499.04K	-38.48%499.04K	-31.45%662.02K	-59.39%462.05K	-71.25%609.51K
Liabilities
Current liabilities
Payables	3.71%1.22M	3.71%1.22M	0.13%1.24M	31.65%1.23M	42.37%1.17M	71.26%1.17M	71.26%1.17M	128.06%1.24M	102.72%934.19K	93.48%820.56K
-accounts payable	-87.84%40.84K	-87.84%40.84K	-81.30%189.82K	-67.44%231.38K	-58.84%245.71K	-27.15%335.92K	-27.15%335.92K	217.67%1.02M	199.57%710.55K	197.79%596.91K
-Due to related parties current	40.46%1.18M	40.46%1.18M	369.82%1.05M	346.46%998.48K	312.48%922.5K	274.18%836.83K	274.18%836.83K	0.00%223.65K	0.00%223.65K	0.00%223.65K
Current debt and capital lease obligation	-3.61%1.3M	-3.61%1.3M	-2.91%1.29M	-16.03%1.29M	-25.47%1.31M	-23.60%1.34M	-23.60%1.34M	-16.97%1.33M	16.18%1.54M	65.00%1.76M
-Current debt	-3.61%1.3M	-3.61%1.3M	-2.91%1.29M	-16.03%1.29M	-25.47%1.31M	-23.60%1.34M	-23.60%1.34M	-16.97%1.33M	16.18%1.54M	65.00%1.76M
Current liabilities	-0.20%2.51M	-0.20%2.51M	-1.44%2.53M	1.98%2.52M	-3.93%2.48M	2.98%2.52M	2.98%2.52M	19.70%2.57M	38.51%2.47M	73.09%2.58M
Non current liabilities
Total non current liabilities	--0	--0	--0	--0	--0	--0	--0	---1	---1	--0
Total liabilities	-0.20%2.51M	-0.20%2.51M	-1.44%2.53M	1.98%2.52M	-3.93%2.48M	2.98%2.52M	2.98%2.52M	19.70%2.57M	38.51%2.47M	73.09%2.58M
Shareholders'equity
Share capital	37.59%3.11K	37.59%3.11K	94.07%3.11K	1,301.35%3.11K	2,183.06%2.83K	1,723.39%2.26K	1,723.39%2.26K	1,192.74%1.6K	-98.49%222	-99.14%124
-common stock	37.59%3.11K	37.59%3.11K	94.07%3.11K	1,301.35%3.11K	2,183.06%2.83K	1,723.39%2.26K	1,723.39%2.26K	1,192.74%1.6K	-98.49%222	-99.14%124
-Preferred stock	----	----	--0	--0	--0	----	----	--0	--0	--0
Retained earnings	-2.87%-24.95M	-2.87%-24.95M	-5.10%-24.89M	-5.24%-24.76M	-16.89%-24.44M	-18.06%-24.26M	-18.06%-24.26M	-18.02%-23.69M	-21.37%-23.53M	-15.20%-20.91M
Paid-in capital	1.04%22.47M	1.04%22.47M	20.33%22.44M	21.81%22.4M	23.37%22.34M	23.34%22.24M	23.34%22.24M	3.94%18.65M	3.21%18.39M	3.54%18.11M
Gains losses not affecting retained earnings	--0	--0	----	----	----	--0	--0	86.82%-330.93K	87.04%-330.93K	-20.48%-2.63M
Other equity interest	----	----	----	----	----	----	----	0.00%3.46M	0.00%3.46M	0.00%3.46M
Total stockholders'equity	-22.94%-2.48M	-22.94%-2.48M	-28.54%-2.45M	-17.25%-2.36M	-6.11%-2.09M	-23.58%-2.02M	-23.58%-2.02M	-61.48%-1.91M	-210.41%-2.01M	-414.67%-1.97M
Total equity	-22.94%-2.48M	-22.94%-2.48M	-28.54%-2.45M	-17.25%-2.36M	-6.11%-2.09M	-23.58%-2.02M	-23.58%-2.02M	-61.48%-1.91M	-210.41%-2.01M	-414.67%-1.97M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data